APDW(アジア太平洋消化器病週間)2021 活動報告
2021-08-31
2021年8月19日-22日にAPDW2021クアラルンプールがWEBで開催され、当教室から以下多数の発表を行いました。
なお、小林貴医師が発表内容を評価されAPDWF-JGHF Educational Grantを受賞しました。
1. Atsushi Nakajima:(Moderator)〈Oral E-Poster2(Liver)〉
2. Atsushi Nakajima:〈Symposium L4:NAFLD/MAFLD SIG Programme 1〉 Risk Stratifying NAFLD Patients for Optimal Care.
3. Yusuke Kurita:〈Oral Presentations5（Liver）〉 IgG4-SC may be a risk for cancer
4. Takaomi Kessoku:〈Oral E-Poster4（Mixed）〉 Retrospective study to investigate a natural history of chronic intestinal pseudo-obstruction in Japan.
5. Takaomi Kessoku:〈Oral E-Poster3（Luminal）〉 Characteristics of fecal microbiota and endotoxin in chronic idiopathic intestinal pseudo- obstruction.
6. Motokazu Sato:〈Oral E-Poster5（Mixed）〉 Usefulness of Computed diffusion weighted MRI with high b value in gallbladder lesions.
7. Shin Yagi:〈Oral E-Poster1（Endoscopy）〉 Efficacy and safety of biliary dilatation balloon catheter for endoscopic ultrasounds-guided hepaticogastrostomy.
8. Michihiro Iwaki:〈ePoster〉 The usefulness of portable ultrasound for constipation in palliative care setting.
9. Noboru Misawa:〈ePoster〉 Safety and efficacy of small-bowel capsule endoscopy in patients with postoperative reconstructed bowel
10. Nobuyoshi Kawamura:〈ePoster〉 Influence of liver stiffness heterogeneity on concordance of MR elastography-based liver fibrosis staging and biopsy results in patients with nonalcoholic fatty liver disease.
11. Akiko Fuyuki:〈ePoster〉 Elobixibat effectively relieves chronic constipation in cancer patients, regardless of food intake amount.
12. Takashi Kobayashi:〈ePoster〉 Effectiveness of naldemedine and magnesium oxide in preventing opioid-induced constipation: proof-of-concept, two-arm, open-label, phase II randomized controlled trial (MAGNET study) .
13. Tsutomu Yoshihara:〈ePoster〉 Effect of leukotriene receptor antagonists on rectal aberrant crypt foci as indicators of risk of colorectal cancer development.
14. Masato Yoneda:〈ePoster〉 Real-world data of cardiovascular disease in patients with metabolic dysfunction-associated fatty liver disease based on medical claim database in Japan.
15. Koki Nagai:〈ePoster〉 Analysis between gastroesophageal varices and spleen stiffness measurement using a novel fibroscan.
16. Misawa Noboru: 〈ePoster〉 Effects of the COVID-19 pandemic on the gastrointestinal cancer stage at diagnosis in Japan.
17. Asako Nogami:〈ePoster〉 Assessment of hepatic fibrosis by vibration controlled transient elastography and MR elastography have equivalent diagnostic performance, but in the assessment of hepatic steatosis, MRI PDFF methods are better than controlled attenuation parameter in over.
18. Yuki Kasai: 〈ePoster〉 Bile acid metabolism in the pathological development of nonalcoholic fatty liver disease.